The Seed Treatment Market Size is valued at USD 6.48 billion in 2023 and is predicted to reach USD 12.35 billion by the year 2031 at a 8.44% CAGR during the forecast period for 2024-2031.
The seed treatment market has gained popularity and acceptance due to key player’s aggregated research and development efforts in launching new & innovative products, which has empowered crop producers to achieve high efficiency in protecting the high-value seeds and further controlling the high loading rates of active chemical ingredients. The novel traits embedded in newly introduced verities and the sharp upward trajectory in the price of products in recent times have compelled them to protect them to ensure appropriate germination of productivity of the crops. The increasing control of pests, insects, & diseases is generally achieved traditionally by applying synthetic pesticides through foliar application methods.
The efficacy and safety of the process act as a better alternative to conventional pest control methods along with the low cost, which can supplement the other control measure to achieve desired results in the field. COVID-19 impacted the growth of the global market restrictions on the movement of vehicles and lockdown. Owing to the market closures, prices of agriculture products such as pesticides and fertilizers also have increased in the range.
Competitive Landscape:
Some of the seed treatment market players are:
- Medtronic Plc (Ireland)
- Boston Scientific Corporation (Us)
- Abbott
- Livanova Plc
- Cochlear Ltd.
- Microport Scientific Corporation
- Sonova
- Nevro Corp.
- Axonics, Inc.
- Neuronetics
- Electrocore, Inc.
- Neuropace, Inc.
- Biotronik
- Medico S.R.L.
- Zhejiang Nurotron Biotechnology Co., Ltd.
- Med-El
- Aleva Neurotherapeutics
- Neurosigma, Inc.
- Soterix Medical Inc.
- Bioinduction (Amber Therapeutics)
- Gimer Medical
- Cefaly
- Biocontrol Medical
- Other Market Players
Market Segmentation:
The seed treatment market is categorized by type, crop type, formulation, application technique, function. Based on type, the market is segmented into chemicals and non-chemicals. The market is segmented by crop type into oilseeds, cereals & grains, fruits & vegetables. oilseeds is sub segmented into soybean, cotton, canola, sunflower. Cereals & grains is sub segmented into corn, wheat, rice, sorghum, barley. fruits & vegetables is sub segmented into solanaceae, cucurbits, brassicas, leafy vegetables, root & bulb vegetables, other fruits & vegetables (other fruits & vegetables include peas, eggplants, and melon), other crop types (turf, forages, alfalfa, and flower seeds.). the market is segmented by formulation into ds - (powder for dry seed treatment), ws - (water dispersible powder for slurry seed treatment), wg - (water dispersible granules), ss - (water soluble powder), ls - (liquid solution), es - (emulsion), fs - (flowable concentrate), cf - (capsule suspension), gf - (gels). The market is segmented by application into seed coating, seed dressing, seed pelleting.
The market is divided into seed protection and seed enhancement. Seed protection is sub segmented into chemical and biological seed protection. chemical segment is sub segmented into insecticides- thiamethoxam, imidacloprid, clothianidin, other insecticides (other insecticides include fipronil and chlorpyrifos.), fungicide- thiram, carbendazim, tebuconazole, carboxin, other fungicides (other fungicides include metalaxyl and ipconazole), other seed protection functions (other seed protection functions include nematicides.)- fumigants, organophosphate, carbamates, other nematicides (other nematicides include acetoprole, benclothiaz, DBCP, and chitosan), biological seed protection is sub segmented into bioinsecticide- bacillus thuringenesis, beavaria bassiana, metarhizium anisopliae, verticillium lecanii, baculovirus, other bioinsecticides (other bioinsecticides include predatory insects, and protozoans), biofungicide- bacillus, trichoderma, streptomyces, pseudomonas, other biofungicidese (other biofungicides include saccharomyces, aureobasidium, and coniothyrium), bionemeticides- microbials, biochemicals.
The seed enhancement is sub segmented into biologicals- biofertilizers, nitrogen-fixing biofertilizers, phosphate solubilizing & mobilizing biofertilizers, potassium solubilizing & mobilizing biofertilizers, other biofertilizers (other biofertilizers include zinc, silica, and sulfur solubilizing biofertilizers), biostimulants, humic substances, seaweed extracts, microbial amendments, amino acids, other biostimulants, (other biostimulants include polysaccharides, trace minerals, vitamins, and antioxidants), plant growth regulators- auxins, gibberellic acid, cytokinins, abcisisic acid biofertilizers, ethylene, seed priming, seed disinfection.
By Crop Type, The Fruits & Vegetables Segment Witnessed Growth At A Rapid Rate
The production and consumption of vegetables to a major role in nutrition and the global population. The production of fruit & vegetables has experienced a remarkable increase, and consumption has also increased and is expected to continue during the forecast period. Moreover, the rising demand for organic fruits & vegetables is driving the growth of not just the seed treatment market but also the adjacent market of biological seed treatment market. Further, the increasing production of high-value vegetable crops, such as lettuce, spinach, hydroponic, tomato, and bell pepper, has increased the scope for developing the seed treatment market.
The Asia Pacific Seed Treatment Market Position Holds A Significant Revenue Share In The Region
Asia Pacific is projected to be the largest-growing region during the forecast period because there is growing demand for fodder crops. The increasing demand for crop protection chemicals in Asia Pacific countries is accelerating the markets during the forecast period. Most established players are expanding their business in the Asia Pacific region, driven by the increasing demand.
Seed Treatment Market Report Scope:
Report Attribute |
Specifications |
Market size value in 2023 |
USD 6.48 Bn |
Revenue Forecast in 2031 |
USD 12.35 Bn |
Growth rate CAGR |
CAGR of 8.44 % from 2024 to 2031 |
Quantitative units |
Representation of revenue in US$ Billion and CAGR from 2024 to 2031 |
Historic Year |
2019 to 2023 |
Forecast Year |
2024-2031 |
Report Coverage |
The forecast of revenue, the position of the company, the competitive market statistics, growth prospects, and trends |
Segments Covered |
Type, Material, Precursor And End Users |
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
Country scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South Korea; Southeast Asia |
Competitive Landscape |
Medtronic Plc (Ireland), Boston Scientific Corporation (Us), Abbott, Livanova Plc, Cochlear Ltd., Microport Scientific Corporation, Sonova, Nevro Corp., Axonics, Inc., Neuronetics, Electrocore, Inc., Neuropace, Inc., Biotronik, Medico S.R.L., Zhejiang Nurotron Biotechnology Co., Ltd., Med-El, Aleva Neurotherapeutics, Neurosigma, Inc., Soterix Medical Inc. and Others. |
Customization scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
Pricing and available payment methods |
Explore pricing alternatives that are customized to your particular study requirements. |